Surgical Robots Market to Reach $22.9 Billion by 2035 at 8.9% CAGR | Intuitive Surgical, Medtronic, Johnson & Johnson

The global surgical robots market, valued at USD 9.8 billion in 2025, will reach USD 10.6 billion in 2026 and climb to USD 22.9 billion by 2035, advancing at a compound annual growth rate (CAGR) of 8.9% across the 2026-to-2035 forecast window. That trajectory reflects sustained investment in robotic-assisted surgery platforms, a broad shift away from open surgical procedures toward minimally invasive techniques, and the accelerating integration of artificial intelligence into surgical workflows. For healthcare executives, device manufacturers, and investors tracking the medical robotics space, the numbers confirm that surgical robotics is one of the fastest-scaling segments in the broader medical technology market.

To explore the complete findings and methodology behind these projections, request a free sample of the report at https://www.rootsanalysis.com/reports/surgical-robots-market/request-sample.html

MARKET OVERVIEW: WHAT IS DRIVING THE SURGICAL ROBOTICS SECTOR
Surgical robots are specialized medical devices that assist surgeons, or in some configurations operate semi-autonomously, in performing complex procedures with a level of precision, dexterity, and visualization that manual techniques cannot consistently replicate. The core value proposition centers on minimally invasive access: smaller incisions, reduced blood loss, lower post-operative infection risk, and shorter hospital stays. These outcomes matter both clinically and commercially, as hospitals managing high daily surgical volumes need systems that improve throughput while protecting patient safety.

The market has expanded well beyond its origins in laparoscopic and urologic procedures. General surgery now accounts for nearly 35% of the market by type of surgical procedure supported, while orthopedic robotic surgery is gaining momentum as developers shift toward open-platform business models that do not require hospitals to purchase proprietary implants. Telesurgery, once a theoretical concept, is entering clinical deployment: Apollo Hospitals Chennai launched the Apollo Institute of Robotics and Telesurgery in March 2026, specifically to advance remote surgical collaboration across India. This kind of institutional commitment signals that the infrastructure for network-mediated robotic surgery is becoming a realistic operational reality, not just an experimental one.

Recent FDA clearances are adding fresh commercial momentum. Medtronic received clearance in December 2025 for its Hugo robotic-assisted surgery system for urologic procedures, followed by a confirmed successful clinical deployment at Cleveland Clinic in February 2026. CMR Surgical's second-generation Versius Plus system also secured FDA clearance in December 2025. These approvals are expanding the addressable procedure base and opening new competitive space for hospitals evaluating their capital equipment pipelines.

KEY GROWTH DRIVERS SHAPING THE SURGICAL ROBOTS MARKET
Rising Preference for Minimally Invasive Surgery. Surgeons and hospital administrators increasingly prefer robotic platforms because they deliver measurable clinical benefits: better dexterity in confined anatomical spaces, enhanced visualization through high-definition imaging, and reduced physical strain on the surgical team. As awareness of these advantages grows among both clinical staff and patients, demand for robotic systems is broadening across procedure categories and geographies.

Artificial Intelligence and Autonomous Capability. AI integration is redefining what surgical robots can do. Companies including Auris Health, IX Innovations, Metamorphosis, and Levita Magnetics are working on AI-assisted robot motion control and autonomous surgical positioning. Current AI applications cover image processing, pre-surgical planning, and anomaly identification in medical imaging. As these capabilities mature, they will reduce dependence on individual surgeon skill and make advanced surgical outcomes more reproducible at scale.
Telesurgery and Remote Connectivity. The convergence of wireless networking and robotic systems is producing viable telesurgical platforms that let surgeons operate from locations remote from the patient. This directly addresses the shortage of specialist surgeons in rural and underserved regions. The commercial and humanitarian case for telesurgery is compelling, and partnerships such as the Ronovo Surgical arrangement with Johnson & Johnson Medical Shanghai, announced in September 2025, show that market participants are already building the distribution infrastructure to scale it.

Miniaturization and Expanding Procedure Compatibility. Device developers are making surgical robots physically smaller and operationally more flexible. Virtual Incision's miniature MIRA system received FDA approval in 2024. This trend reduces capital barriers for smaller hospitals and ambulatory surgery centers, extending the buyer base beyond large academic medical centers. At the same time, companies are filing for clearance across wider procedure categories, with SS Innovations International's SSi Mantra system seeking FDA authorization for five distinct surgical disciplines in December 2025.

Strategic Partnerships and M&A Activity. Acquisitions account for approximately 14% of all industry deals signed since 2019, the highest single deal type by share. This consolidation reflects both the high barriers to achieving full-platform capability and the competitive urgency to build broader technology portfolios. Startups are also attracting capital, with Panda Surgical raising USD 1.34 million for a handheld neurosurgical robot as recently as October 2025.

MARKET SEGMENTATION: INSTRUMENTS LEAD, CLOUD MODELS ACCELERATE
By offering type, the instruments and accessories segment holds the largest share of the surgical robots market. This is structurally significant: surgical robot companies generate recurring revenues through the consumable instruments and accessories used in every procedure, creating a durable revenue stream that complements one-time system sales. The services segment, covering training programs and maintenance, will grow at the highest CAGR among all offering types through 2035, driven by the growing sophistication of AI-integrated robotic systems that require more intensive surgeon training and technical upkeep.

By deployment model, on-premises systems dominate current revenues. However, cloud and remote deployment models will outpace on-premises growth over the forecast period, as telesurgery infrastructure matures and healthcare networks prioritize geographic access over localized capital ownership. By end user, hospitals capture the highest market share today, given their high surgical volumes and capital capacity. Ambulatory surgery centers represent the fastest-growing end-user category as miniaturized platforms bring robotic surgery within their operational and financial reach. By application area, the therapies and treatment segment leads in share; diagnostics is the faster-growing sub-segment going forward.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/surgical-robots-market/request-quote.html

REGIONAL INSIGHTS: NORTH AMERICA LEADS, ASIA PACIFIC ACCELERATES
North America holds the dominant share of the global surgical robots market, accounting for approximately 70% of overall market size in 2026. The United States is the primary contributor, supported by a well-established hospital infrastructure, high healthcare spending per capita, an active FDA regulatory pathway that is processing robotic device clearances at an increasing rate, and strong concentration of leading developers including Intuitive Surgical, Medtronic, and Stryker. The pipeline of recent FDA approvals confirms that North America will remain the primary commercial launch market for new surgical robotic platforms through the forecast period.

Asia Pacific is the fastest-growing region, with China, Japan, and India each contributing distinct growth dynamics. India is seeing institutional commitment at the system level, with the Apollo Institute of Robotics and Telesurgery representing a deliberate national push toward robotic and remote surgical capability. In China, strategic partnerships between domestic companies and global players such as the Ronovo Surgical-Johnson & Johnson Medical Shanghai arrangement are accelerating adoption in a hospital system that manages some of the world's highest surgical volumes. Europe maintains a meaningful share of the market, supported by national health systems in Germany, the United Kingdom, and France that are progressively integrating robotic platforms into standard surgical protocols.

COMPETITIVE LANDSCAPE: ESTABLISHED LEADERS AND EMERGING CHALLENGERS
The surgical robots market includes over 110 active developers tracked in the full Roots Analysis report. Key players include Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Smith+Nephew, Zimmer Biomet, Siemens Healthineers, CMR Surgical, Caranx Medical, Great Robotics, Microsure, NDR Medical Technology, Renishaw, Riverfield, ROEN Surgical, Sina Robotics and Medical Innovators, Shanghai MicroBot MedBot, Tuodao Medical, Panasonic, Freehand, and Abbott, among others.

Intuitive Surgical has led this market for multiple decades and continues to define the premium robotic surgery tier with its da Vinci platform family. The competitive dynamic, however, is shifting. Medtronic's Hugo system and CMR Surgical's Versius Plus represent a new wave of credible alternatives with broad procedure coverage and recently cleared regulatory status. Acquisitions continue as the primary consolidation mechanism, with 14% of all deals since 2019 being buyouts. The main battlegrounds are IP differentiation, geographic expansion particularly into Asia Pacific, regulatory clearance speed across new procedure types, and the race to embed AI autonomy into robotic platforms before a competitor does.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/surgical-robots-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.